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The nervous system processes
sensory information and controls
behavior by performing an
enormous number of
computations. These
computations occur both within
cells and between cells, but it is
intercellular information
processing, involving complex
neural networks, that provides the
nervous system with its
remarkable functional capacity.
The principal cells involved in
information processing are
neurons, of which there are
hundreds, if not thousands of
individual cell types based on
morphology, location, connectivity
and chemistry [1]. In addition to
neurons, the other major kind of
cell in the nervous system is the
glia, which play critical support
roles, but which are increasingly
seen to function in some aspects
of information processing.
To provide some idea of the
magnitude of the information
processing capacity of the human
brain, its 1011 neurons make, on
average, about 1000 connections
or synapses, at which
communication occurs with other
neurons. The range of synapses
per cell is very large; the Purkinje
cells of the cerebellum may
receive 100,000 contacts from
input cells. Overall the human
brain may contain between 1014
and 1015 synaptic connections. 
The diverse chemical
substances that carry information
between neurons are called
neurotransmitters. Otto Loewi
discovered the first
neurotransmitter in 1926 when he
demonstrated that acetylcholine
carried a chemical signal from the
vagus nerve to the heart that
slowed the cardiac rhythm. Since
that time, more than one hundred
substances and a far larger
number of receptors have been
implicated in synaptic
transmission (Box 1). Because of
the remarkably diverse effects of
neurotransmitter-mediated
signaling at the receptor and post-
receptor levels, the number of
neurotransmitters, as large as it is,
vastly understates the complexity
of signaling in the brain.
In the nervous systems of
higher animals, only a small
fraction of neurons are directly
involved in transducing sensory
information or controlling output
cells, such as endocrine, smooth
muscle or striated muscle cells.
The vast majority form what Nauta
[2] called the great intermediate
net, which underlies the
extraordinary computational
power of the brain. The complex
set of neuronal networks
interposed between input and
output neurons form the basis,
inter alia, for learning complex
motor sequences, for thought,
emotion, for ‘top down’ behavioral
control and, in humans, for such
functions as language, writing
poetry and planning wars.
In addition to performing
present-oriented computations,
the nervous system is plastic; it
alters itself (forms memories) as it
processes information, so that it
can respond more adaptively in
the future. The subtlety and
complexity of the brain’s outputs,
along with its ability to change in
response to new information, is
supported by a rich set of
mechanisms for cell–cell
communication involving at an
anatomical level, intricate but
plastic local connections, larger
scale neural circuits and overlying
global regulatory systems; and at
the chemical level, a large number
of neurotransmitters with highly
diverse mechanisms for decoding
their informational content.
Because neurotransmitters play
such a central role in brain
function, neurotransmitter
receptors and other proteins
involved in neurotransmitter
synthesis and inactivation are
critical targets for the
development of therapeutic drugs
meant to treat psychiatric and
neurologic disorders, pain, and a
host of other ills [3]. Moreover,
natural substances, such as
cocaine, opiates, nicotine, ethyl
alcohol and LSD, that can mimic
or interfere with actions of
neurotransmitters, exert potent
effects on human behavior [3].
Neurons are specialized to
receive, process, and transmit
information (Figure 1). As a first
approximation, information is
represented electrically within
neurons and chemically (by
neurotransmitters) between
neurons. Once released,
neurotransmitters diffuse across
the synapse to bind to
postsynaptic receptors. It should
Monoamines and acetylcholine
Acetylcholine
Dopamine
Norepinephrine
Epinephrine
Serotonin
Histamine
L-Amino acids
Glutamate
Aspartate
Gamma aminobutyric acid (GABA)
Glycine
D-Amino acid
D-Serine
Purines
Adenosine
Adenosine triphosphate (ATP)
Gases
Nitric oxide (NO)
Carbon monoxide (CO)
Lipids
Anadamide (endocannabinoid)
2-arachidonoylglycerol (2-AG)
(endocannabinoid)
Peptides (very truncated list)
Enkephalins (endogenous opioid
peptides)
Beta-Endorphin (endogenous opioid
peptide)
Dynorphins (endogenous opioid
peptides)
Substance P
Neuropeptide Y (NPY)
Peptide YY (PYY)
Orexin (also known as hypocretin)
Vasopressin
Oxytocin
Corticotrophin releasing hormone (CRH)
Somatostatin
Neurotensin
Bombesin
Galanin
Vasoactive intestinal polypeptide (VIP)
Bradykinin
Box 1. Partial list of
neurotransmitters organized by
chemical properties.
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Table 1. Properties of exemplary neurotransmitters.
Chemical Example Cell of origin Storage Release and other Inactivation Receptors
class mechanisms
of initiating signaling 
Acetylcholine Acetylcholine Neurons Vesicles Depolarization Enzymatic Ionotropic (nicotinic) 
(acetylcholinesterase) and GPCR (muscarinic)
Amino acids Glutamate Neurons Vesicles Depolarization Transporters Ionotropic and GPCR
Monoamines Dopamine Neurons Vesicles Depolarization Transporter GPCRs
Peptides Enkephalin Neurons Vesicles, often Repetitive Enzymatic (for many GPCRs µ, δ, opiate
separate from depolarization peptides relevant receptors
small molecule enzymes or other 
neurotransmitters mechanisms are
unknown)
D-Amino acids D-Serine Astrocytes Unknown Activation of Transporter Modulatory (glycine) site
(glia) serine racemase on NMDA
followed by glutamate receptors
release of resulting
D-Serine by 
unknown mechanisms
Purines Adenosine Neurons and ATP is stored (1) Liberation from Transporter GPCRs
probably in vesicles and diverse extracellular
others may be rapidly purines by 
hydrolyzed to ectoenzymes
adenosine after (2) Facilitated
release; high diffusion out
basal  extra- of cells
cellular levels
represent unstored 
adenosine
Gases NO Neurons None Ca2+-dependent Diffusion. Perhaps Many enzymes 
regulation of enzymatic containing transition 
nitric oxide degradation metals; such as soluble
synthase (nNos) to guanylyl cyclase
produce NO for
immediate diffusion
Lipids Anadamide Neurons Unknown if Probably released Transporter followed GPCRs
stored into synapse but by hydrolysis (cannabinoid)
diffusion mechanism 
in aqueous medium
unclear
(1) These examples are not fully extendible to the class. For example the purine adenosine triphosphate (ATP), which despite its ubiquity as an
energy carrying molecule can also carry information [10], is colocalized in vesicles with other neurotransmitters, such as, acetylcholine or
dopamine, and is released by depolarization; while the purine adenosine is released by facilitated diffusion. ATP interacts with both ionotropic
receptors (P2X receptors) and G-coupled receptors (P2Y receptors), while adenosine only interacts with G-coupled receptors. (2) As alluded
to in the text, glia may, in some cases, be directly involved in neurotransmitter action: for example by inactivation of neurotransmitter, such as
glutamate, or by release, for example of ATP or D-Serine [11]. 
be noted that, in addition to
chemical synapses, which
represent the vast majority, there
are also electrical synapses,
which permit the flow of ions
between cells through gap
junctions. Electrical synapses,
which will not be further
discussed here, permit simple
electrical signals to pass between
neurons, whereas chemical
synapses, as will be seen, permit
excitatory, inhibitory and complex
biochemical information to pass
between cells. There are, in fact, a
wide variety of molecular
structures that have been found to
act as neurotransmitter receptors,
but the most numerous are
ligand-gated channels and G
protein-coupled receptors
(GPCRs; Figure 2 and Table 1).
The major structural elements
of a chemical synapse are a
presynaptic nerve terminal, a
postsynaptic structure that
contains neurotransmitter
receptors and an appropriate
intracellular signaling apparatus,
and the synaptic cleft in between
(Figure 3). At most chemical
synapses, neurotransmitter is
stored within synaptic vesicles,
several thousand molecules per
vesicle. Gaseous
neurotransmitters, such as NO
and CO, cannot be stored
(Table 1). Synaptic vesicles are
clustered at specialized regions of
membrane within the presynaptic
terminal called active zones,
which also contain a high density
of voltage-gated Ca2+ channels. 
In a classical case of chemical
transmission, a neurotransmitter
is released by a presynaptic
neuron and binds to receptors on
the postsynaptic neuron; typically
these receptors are localized on
dendrites — filamentous
extensions from the neuron’s cell
body that are the primary
receiving structures of the cell
(Figure 1). Chemical information is
converted by receptors and
associated proteins into electrical
information by the activation of
ion channels. In the simplest case,
such as nicotinic acetylcholine
receptors or γ-aminobutyric acid
(GABAA) receptors, the channel is
an intrinsic component of the
neurotransmitter receptor itself
(Figure 2). 
At rest the neuronal membrane
is polarized, bearing a negative
charge. By regulating ion
channels, neurotransmitter
binding can activate ion fluxes
across the membrane. Depending
on which types of channel are
activated, either ‘hyperpolarizing’
negative charges or ‘depolarizing
positive charges’ may enter the
cell. The balance of negative and
positive charge is integrated
within the dendrites and cell body
of the neuron, and if a threshold of
depolarization is reached,
specialized voltage-gated Na+
channels open in succession,
generating a wave of
depolarization down the axon, an
‘action potential’. 
When an action potential arrives
at the distal end of the axon — the
presynaptic terminals — the
inrush of positive charge activates
voltage-sensitive Ca2+ channels.
Ca2+ entry then initiates
processes by which vesicles fuse
with the presynaptic cell
membrane releasing
neurotransmitter into the synaptic
cleft. When neurotransmitters,
such as acetylcholine or
glutamate, activate cation (for
example Na+ or Ca2+) channels,
and are thus depolarizing, they
can be described as excitatory;
when neurotransmitters, such as
GABA, activate anion (for example
Cl–) channels, they can be
described as inhibitory.
As noted above,
neurotransmitters often have
more than one receptor. For many
neurotransmitters, the receptors
may be structurally and
functionally quite distinct. Thus,
in addition to having receptors
that are ligand-gated channels,
acetylcholine, glutamate and
GABA also have receptors that
are coupled to G proteins. Most
of the receptors for monoamine
neurotransmitters (Box 1) and all
known receptors for
neuropeptides are G protein-
coupled receptors, sometimes
described by the ungainly term,
metabotropic receptors (meant to
contrast them with ionotropic
receptors). G protein-coupled
receptors activate biochemical
cascades involving G proteins,
second messengers and protein
kinases (Figures 2 and 3). The
activation of a G protein-coupled
receptor may lead to changes in
membrane potential, but the
onset is slower than that caused
by a ligand-gated channel
because in this case the channel
is a separate molecule that must
be activated by a G protein,
second messenger or protein
kinase, in all cases a multistep
process. 
In some cases, activation of a G
protein-coupled receptor has no
significant effect on the
membrane potential, but by
activating protein kinases that
phosphorylate ion channels, for
example, it may alter the
subsequent responsiveness of the
neuron to excitatory or inhibitory
neurotransmission. By activating
second messenger systems,
protein kinases and gene
expression, G protein-coupled
receptors and those ligand-gated
channels that permit entry of Ca2+
(in its own right a second
messenger) can also initiate
functional [4] and structural
changes in neurons [5] that
provide the substrate for long-
term memory.
Not all released
neurotransmitter molecules find a
receptor to which to bind. In order
to maintain the fidelity of synaptic
transmission, the action of excess
neurotransmitter in the synapse
must be rapidly terminated to
avoid diffusion of high
concentrations of
neurotransmitter to inappropriate
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Figure 1. Chemical
neurotransmission occurs
across synapses. 
Neurons are asymmetric
cells with dendrites acting
as the major, but not the
only, receptive region of the
cell. Neurotransmitter
receptors are found not only
on dendrites, but also on
cell bodies and presynaptic
terminals. Axons are the
information transmitting
structures that release
neurotransmitters from their
terminals. Shown here is the
classical arrangement for
communication with the
axon of the presynaptic cell
contacting a dendritic spine
(see inset), a feature of
many neuronal cell types,
but axons may also contact
cell bodies and other axons.
As described in the text, a
chemical message is
received by the post-
synaptic neuron and is
converted into an electrical
signal within dendrites. The electrical information would then be integrated within
dendrites and the cell body, and if it reaches an adequate threshold of depolarization,
the electrical information is transmitted down the axon of the receiving neuron to its
presynaptic terminal (not shown). In the presynaptic terminal, the cycle of synaptic
transmission is renewed as the electrical signal of the action potential is converted into a
new chemical signal. While the most common direction of communication is from
presynaptic neuron to postsynaptic neuron in a circuit, as shown here, both autocrine-
like feedback onto ‘autoreceptors’ and retrograde neurotransmission occur. In the latter
cases, gaseous and lipid neurotransmitters such as endocannabinoids may play an
important role [12]. (Adapted with permission from [3].)
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Dendritic
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terminal
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synapses. The most common
mechanism of neurotransmitter
inactivation involves
neurotransmitter-specific
transporters, which may be
located on the presynaptic
terminal (as in the case, for
example, of norepinephrine,
serotonin and dopamine), or in
some cases on neighboring glial
cells (as with some glutamate
transporters). 
Less commonly,
neurotransmitters are inactivated
by enzymatic degradation, as is
the case for acetylcholine, which
is degraded by a highly active
ectoenzyme acetylcholinesterase,
located within cholinergic
synapses (Table 1). Several
peptide neurotransmitters have
been shown to be degraded by
enzymes but, unlike small
molecule neurotransmitters,
peptides may diffuse for
substantial distances within the
nervous system before finding
targets or being degraded [6].
Neurotransmitters with a long
diffusion radius are obviously not
involved in the kind of precise
point-to-point information transfer
that might characterize the basic
functions of the visual system, for
example.
Historically, the problem of
determining which molecules
actually function as
neurotransmitters has not been a
trivial one. This problem is
illustrated by the observation that
both glutamate and ATP can
serve as neurotransmitters. The
vast preponderance of both
molecules is in other cellular pools
where they act, for example, as
building blocks of proteins and
nucleic acids, respectively, or in
intermediary metabolism. Thus,
there has long been a concern
with setting experimental criteria
for determining that a substance
was a neurotransmitter. 
There is no full agreement on
the experimental criteria, but one
representative set (adapted from
[7]) would make the following
stipulations: (1) the presynaptic
neuron contains the appropriate
synthetic enzymes to produce the
substance, or in the case of
neuropeptides, expresses the
appropriate gene(s); (2) the
substance is released upon
stimulation of the presynaptic
neuron; (3) when the substance is
applied experimentally to the
postsynaptic cell, it mimics
normal synaptic transmission; (4)
there is a local mechanism to
terminate the action of the
putative transmitter; (5)
postsynaptic cells contain
receptors for the putative
neurotransmitter; (6) antagonists
that block the effects of the
substance when applied
experimentally also block the
effect of normal
neurotransmission at relevant
synapses.
In truth many substances
broadly considered to be
neurotransmitters have not fully
met all of these criteria. For
example, many peptides lack
selective antagonists, and in some
cases mechanisms of inactivation
remain to be discovered. The
difficulty of characterizing
transmission at a particular set of
synapses is also complicated by
the recognition, dating from the
1970s, that neurons often release
more than one neurotransmitter
from the same presynaptic
terminals, most often a small
molecule together with one or
more peptides [8]. The recognition
that gases such as NO and CO
can function as neurotransmitters
means that not all
neurotransmitters are stored in
vesicles — these gases diffuse
across membranes as soon as
they are synthesized. Indeed, not
all putative neurotransmitters are
synthesized in neurons: D-Serine
is synthesized in the protoplasmic
astrocytes that surround
synapses [9].
Attempts have also been made
to find conceptual groupings of
neurotransmitters. Perhaps the
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Figure 2. Neurotransmitter receptors.
As more substances are recognized to act as neurotransmitters, the diversity of molecules that serve as receptors also grows. For
example, NO receptors are metal-containing enzymes. By far the most numerous neurotransmitter receptors are ligand-gated
channels (left) and G protein-coupled receptors (right). Both have an extracellular ligand binding domain and a mechanism to convert
extracellular ligand binding to a cellular signal. The ligand-gated channels do this by opening a central pore that permits ions to pass.
The G-coupled receptors transmit a signal across the membrane to activate trimeric G proteins and their cognate signaling cascades,
most often activating or inhibiting second messenger generating enzymes.  (Adapted with permission from [3].)
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least problematic groupings are
those based on the chemical
nature of the substances (Box 1
and Table 1 are organized in this
fashion). Chemical groupings are
far from perfect with respect to
function, but proposed functional
groupings have been hampered
by the fact that neurotransmitters
have multiple receptors and that
it is the receptor rather than the
neurotransmitter that actually
determines function. The most
broadly disseminated proposal
was to reserve the term
neurotransmitter for those
substances that produced rapid
changes in the membrane
potential of the receiving neuron
(via ligand-gated channels), and
to apply the term neuromodulator
to substances that initiated
slower-onset biochemical
changes in postsynaptic neurons
(via G protein-coupled receptors,
for example). The term
neuromodulator was never really
successful, however, because a
large number of
neurotransmitters induce both
excitatory or inhibitory
postsynaptic electrical potentials
as well slow-onset biochemical
changes. For example, glutamate
is the most significant excitatory
neurotransmitter in the brain,
acting at several families of
receptors that are ligand-gated
channels, but it also initiates
complex biochemical functions
within neurons via its
metabotropic receptors, which
are G protein-coupled receptors.
Serotonin (5 hydroxytryptamine
or 5-HT) has thirteen known
receptors, twelve of which are G-
coupled receptors and one, the
5-HT3 receptor, that is a
ligand-gated channel. In short,
serotonin might be called a
neuromodulator, except when it
isn’t... Unfortunately for those
scientists with an intense need
for simple classifications,
evolution was a tinkerer that has
reused signaling molecules to
different effect in many different
contexts.
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Figure 3. Key features of a cholinergic synapse.
The major features of a synapse are the presynaptic and postsynaptic terminals and
the cleft. Within the presynaptic terminal, neurotransmitter is contained in vesicles typ-
ically docked along the plasma membrane in a region known as the active zone. When
an action potential signal invades the presynaptic terminal, voltage-sensitive Ca2+ chan-
nels found at high density near the area of the active zone open, and the inrush of
calcium initiates the complex process by which vesicles rapidly fuse with the mem-
brane of the presynaptic terminal, dumping neurotransmitter into the synapse. Neuro-
transmitter diffuses across the synapse, where it finds appropriate neurotransmitter
receptors. Acetylcholine has receptors that are ligand-gated channels, the nicotinic
acetylcholine receptors (nAChR), and also muscarinic receptors, which are G-coupled
(the five subtypes known are depicted as M1–M5). The presynaptic terminal also con-
tains the biosynthetic machinery to produce the neurotransmitter, and in this case, a
transporter for the precursor, choline. Neurotransmitter is loaded into vesicles via a
vesicular transporter. The action of acetylcholine in the synaptic cleft is terminated by
the ectoenzyme, acetylcholinesterase (AChE). (Adapted with permission from [3].)
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